ClinicalTrials.gov record
Recruiting Not applicable Interventional

The Dragon PLC Trial (DRAGON-PLC)

ClinicalTrials.gov ID: NCT06914648

Public ClinicalTrials.gov record NCT06914648. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The DRAGON PLC Trial - An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) With PVE Alone in Primary Liver Cancers.

Study identification

NCT ID
NCT06914648
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Maastricht University
Other
Enrollment
358 participants

Conditions and interventions

Interventions

  • Hepatic Vein Embolization Procedure
  • Portal Vein Embolization Procedure

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2025
Primary completion
Nov 14, 2032
Completion
Nov 14, 2032
Last update posted
May 14, 2025

2025 – 2032

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Yale School of Medicine Hospital New Haven Connecticut 06510 Not yet recruiting
Rush University Medical Center Chicago Illinois 60612 Not yet recruiting
Mayo Clinic Rochester Minnesota 55905 Not yet recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Not yet recruiting
Cleveland Clinic Cleveland Ohio 44195 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06914648, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06914648 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →